| | ORTHOLOGY: K08860 | |
Entry |
|
Symbol |
EIF2AK3, PERK
|
Name |
eukaryotic translation initiation factor 2-alpha kinase 3 [EC: 2.7.11.1]
|
Pathway |
map04141 | Protein processing in endoplasmic reticulum |
map04932 | Non-alcoholic fatty liver disease |
map05022 | Pathways of neurodegeneration - multiple diseases |
map05168 | Herpes simplex virus 1 infection |
|
Disease |
H00766 | Wolcott-Rallison syndrome |
|
Brite |
KEGG Orthology (KO) [BR:ko00001]
09120 Genetic Information Processing
09123 Folding, sorting and degradation
04141 Protein processing in endoplasmic reticulum
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
04137 Mitophagy - animal
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
09143 Cell growth and death
04210 Apoptosis
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
04214 Apoptosis - fly
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
09160 Human Diseases
09172 Infectious disease: viral
05160 Hepatitis C
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
05162 Measles
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
05168 Herpes simplex virus 1 infection
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
09164 Neurodegenerative disease
05010 Alzheimer disease
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
05012 Parkinson disease
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
05014 Amyotrophic lateral sclerosis
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
05020 Prion disease
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
05022 Pathways of neurodegeneration - multiple diseases
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
09167 Endocrine and metabolic disease
04932 Non-alcoholic fatty liver disease
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
Enzymes [BR:ko01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.1 non-specific serine/threonine protein kinase
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
Protein kinases [BR:ko01001]
Serine/threonine kinases: Other
PEK family [OT]
K08860 EIF2AK3, PERK; eukaryotic translation initiation factor 2-alpha kinase 3
|
Other DBs |
|
Genes |
» show all
|
Reference |
|
Authors |
Schroder M, Kaufman RJ |
Title |
Divergent roles of IRE1alpha and PERK in the unfolded protein response. |
Journal |
|
Reference |
|
Authors |
Baltzis D, Pluquet O, Papadakis AI, Kazemi S, Qu LK, Koromilas AE |
Title |
The eIF2alpha kinases PERK and PKR activate glycogen synthase kinase 3 to promote the proteasomal degradation of p53. |
Journal |
|
Reference |
|
Authors |
Shi Y, An J, Liang J, Hayes SE, Sandusky GE, Stramm LE, Yang NN |
Title |
Characterization of a mutant pancreatic eIF-2alpha kinase, PEK, and co-localization with somatostatin in islet delta cells. |
Journal |
|
Sequence |
|
|
|
|